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The inclusion complex is one way to enhance active substance solubility, affecting medicine 
dissolution and penetration. The inclusion complex is formed by utilizing -cyclodextrin as the host of 
the active compounds. The Ibuprofen (2-(4-isobutyl-phenyl)propionate) is a propionate acid derivative 
and classified in class II of the Biopharmaceutic Classification System, which has low dissolutions and 
high permeability. This study aims to develop a nanogel containing ibuprofen-β-cyclodextrin inclusion 
complex with the ratio of 1:1, 1:2 and 2:1; and to compare the in-vitro diffusion profile with pure 
ibuprofen gel. The inclusion complex of ibuprofen-β-cyclodextrin was prepared using the 
coprecipitation method with the three molar comparison ratio of 1:1, 1:2, and 2:1. The in-vitro study 
was performed using the gel-based viscolam, comparing the three formulas of ibuprofen-β-
cyclodextrin with pure ibuprofen gel. The ibuprofen concentration of each gel tested in the experiment 
was 1%. The particle size characterization of ibuprofen-β-cyclodextrin inclusion complex gel resulted 
in having nanoparticle size (510 nm). This characteristic indicates that the inclusion complex gel could 
enhance the cumulative release amount of ibuprofen compared with pure ibuprofen gel with a 
relatively smaller particle size (156 nm). Pure ibuprofen and inclusion complex powder size measured 
to be 763 nm and 957 nm, respectively. The ibuprofen--cyclodextrin inclusion complex gel with a 
molar ratio of 2:1 demonstrated an increase in in-vitro diffusion profile of ibuprofen with a cumulative 
release amount of 740.3 µg.cm
-2
. Meanwhile, pure ibuprofen gel had the cumulative release amount of 
294.74 µg.cm
-2
. The gel containing ibuprofen-β-cyclodextrin inclusion complex could enhance the 
cumulative release amount of ibuprofen compared to pure ibuprofen gel. The ibuprofen-β-cyclodextrin 
inclusion complex gel at a ratio of 2:1 exhibited an increase in the diffusion of ibuprofen in-vitro. 
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The purpose of inclusion complex formation is to improve drug solubility. This form will also 
affect the percutaneous drug penetration. Ibuprofen (IBP) is an arylacetic acid derivative which has 
high antipyretic and analgesic activity (Katzung et al., 2012). Based on the Biopharmaceutic 
Classification Systems, IBP is classified as class II with high permeability and low solubility. Drug 
with low solubility will also have a low dissolution rate resulting in imperfect absorption and low 
bioavailability (Chaudhary and Patel, 2013). 
-cyclodextrin (BCD) is an oligosaccharide that belongs to the cyclodextrin group. The formation 
of the IBP inclusion complex with BCS occurs where the BCD acts as a host with the IBP molecule as 
the guest. The inner cavity of cyclodextrins is hydrophobic, allowing hydrophobic drug molecules to 
be confined in it to form an inclusion complex with non-covalent bonds. In contrast, the outer cavity is 
hydrophilic so that the drug complex dissolves easily in water (Liu, 2008). 
IBP orally is available commercially in both solid and liquid form. However, the limitation of 
IBP solubility in the gastrointestinal fluid cause a low rate of drug dissolution. Therefore, this problem 
can be countered by preparing a transdermal type of drug, the nanogel. Nanogel is a drug delivery 
system through the skin or transdermal with particle size around 1-1000 nm. Several advantages of 
nanogel form over cream are that the nanogel is relatively more comfortable to be applied with a 
cooling sensation. Furthermore, this type could increase drug penetration rate due to its small particle 
size (Agustin et al., 2007) 
The ability of the active substances to penetrate the lower layers of the skin determines the 
effectiveness of transdermal drug administration. A drug needs to penetrate the stratum corneum, 
which is the outermost part of the skin, to reach the lower layers of the skin. In principle, the entry of 
the penetrant into the stratum corneum is the partition coefficient of the penetrant (Loftsson and 
Brewster, 1996). Hydrophilic drugs will penetrate the stratum corneum through transcellular transport, 
while lipophilic drugs will penetrate through intercellularly. The entry of drug molecules from the skin 
surface into the tissue under the skin and end up in the blood circulation occurs by passive diffusion 
called transdermal (Patil et al., 2010). 
This study was conducted to develop a nanogel containing ibuprofen-β-cyclodextrin inclusion 
complex with the molar ratio of 1:1, 1:2, and 2:1; followed by in-vitro diffusion profile comparison to 
pure ibuprofen gel. 
 
MATERIALS AND METHODS  
Materials   
Ibuprofen (IOL Chemical & Pharmaceutical LTD, India), β- cyclodextrin (Roquette, France), 
viscolam MAC 10 (Lamberty, Italy), HT Tuffryn Polysulfone membrane (Pall Corporation, USA), 
ethyl eter, phosforic acid, potassium hydrogen phosphate, propylene glycol, triethanolamine, 
glycerine, propylparaben, methylparaben and sodium hydroxide (Sigma-Aldrich, USA) and rat skin 




Preparation of IBP-BCD inclusion complexes using coprecipitation method 
Preparation of the inclusion complex of ibuprofen (IBP) in β-cyclodextrin (BCD) was 
performed using the coprecipitation method at a molar ratio of 1:1, 1:2 and 2:1. The molecular weights 
of IBP and BCD are 206.28 g/mol and 1135 g/mol, respectively. The BCD was diluted and 
homogenized in aquadest using a magnetic stirrer at 50℃, followed by adding NaOH into the solution. 
After that, IBP was added and homogenized at 60
o
C for 10 hours. After that, precipitation was 
formed by evaporating the water content in an oven at 70
o
C. The precipitation powder was then 
refined using mortar (Agustin et al., 2007). 
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Determination of ibuprofen concentration in inclusion complexes 
The powder of the IBP-BCD inclusion complex was weighed with three different molar ratio of 
1:1, 1:2, and 2:1, which equivalent to 10 mg of pure IBP. Later, each formulation was diluted in 100 
ml of phosphate buffer saline (PBS) pH 7.4. Ibuprofen concentration was determined using a 
spectrophotometer with a wavelength of 223 nm. The experiment was conducted in triplicate repetition 
(Widjaja et al., 2014). 
 
Partition coefficient determination in phosphate buffer pH 7.4 and chloroform (1:1) 
Powder IBP-BCD inclusion complex with the molar rate of 1:1, 1:2 and 2:1, equivalent with 
125mg pure IBP powder, was diluted in 25 mL PBS with pH 7.4. The solution was put into a 
separating funnel and added with an equal volume of chloroform, and mixed until it reached 
equilibrium. After that, let the solution sit still until it was divided into two fractions. The water 
fraction was taken to determine the IBP-BCD inclusion complex concentration using an ultraviolet 
spectrophotometer with a wavelength of 223 nm. The same procedure was also done to pure IBP 
powder. All of the experiment was done in triplicate replication (Sinko, 2011). 
 
Partition coefficient determination in phosphate buffer pH 7.4 and skin 
Powder of IBP-BCD (100 mg) was added into 10 mL PBS pH 7.4 and was homogenized for 25 
hours at 25°C. The initial IBP concentration was determined using an ultraviolet spectrophotometer 
with a wavelength of 223 nm. 
The rat skin was shaved and cleaned using 1% trypsin. Later, 100-150 mg of treated rat skin was 
put into the test solution with specified volume and was homogenized for another 24 hours at 25°C. 
Following that, filter the solution and evaluate the final IBP concentration using an ultraviolet 
spectrophotometer with a wavelength of 223 nm. 
The same procedure was also conducted in pure IBP powder. The experiment was done in 






C0 = Concentration of IBP in phosphate buffer pH 7,4 (mg/mL) 
C1 = Concentration of IBP after shaking with the skin (mg/mL) 
Wskin = Weight of skin (mg) 
V = Volume of test solution when the skin was inserted (mL) 
(Sinko, 2011) 
 
Preparation of nanogel  
In this study,  pure IBP gel and IBP-BCD inclusion complex gel was prepared with the molar 
rate of 1:1, 1:2 and 2:1. Each formula contains 1% of IBP, which have anti-inflammation property. 
The gelling agent used in the preparation was 5% of Viscolam MAC 10, which is emollient with a 
non-irritating transparent gel texture (Edityaningrum and Rachmawati, 2015; Nurdianti, 2015; 
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Table 1. Formulation of nanogel preparation 
Formulation 
(% w/w) 
F1 F2 F3 F4 
IBP pure 1 - - - 
IBP-BCD (1:1) inclusion complex - 1 - - 
IBP-BCD (1:2) inclusion complex - - 1 - 
IBP-BCD (2:1) inclusion complex - - - 1 
Viscolam MAC 10 5 5 5 5 
Propylene glycol 15 15 15 15 
Glycerin 5 5 5 5 
Triethanolamine q.s q.s q.s q.s 
Propylparaben 0.02 0.02 0.02 0.02 
Methylparaben 0.18 0.18 0.18 0.18 
Aquadest Ad 100 Ad 100 Ad 100 Ad 100 
 
To make the nanogel, pure IBP powder and IBP-BCD powder respectively combined in 
propylene glycol and mixed using a magnetic stirrer. After that, the mixture of glycerine, 
propylparaben and methylparaben was added, followed by the gradual addition of aquadest and 
viscolam MAC 10. Finally, the pH level was adjusted using triethanolamine until it reached around 6-
7 and thick viscosity before the gel was evaluated.  
 
Characterization and performance evaluation of nanogel  
Organoleptic 
Organoleptic observation, including shape, colour and smell, was done on the prepared nanogel 
(Priani et al., 2018). 
 
Homogeneity 
A little bit of nanogel was placed evenly between two glass objects to observe the sample’s 
homogeneity under a microscope (Priani et al., 2018). 
 
pH 
The acidity level was measured using a pH meter at room temperature. Firstly, the electrode was 
calibrated using the buffer solution (pH 4 and 7). After that, the electrode was immersed into the 
prepared gel until the pH value was shown on the screen (Priani et al., 2018). 
 
Dispersibility  
The prepared gel (0.5g) was put on a flat glass (20 x 20 cm). A load was put on top of the gel 
until it weights 150 g. After 5 minutes, the spreading diameter was measured (Priani et al., 2018). 
 
Viscosity and rheology 
The rheological properties determination of gel was performed by Brookfield digital viscometer 
(RV D 220). The viscosity of preparation was measured at varying rotational speeds of the spindle (10; 
20; 50; 100; 50; 20; 10 rpm). The viscosity measurement was done using spindle number 62 at the 
speed of 50 rpm (Priani et al., 2018; Sabale and Vora, 2012). 
 
Drug Content 
About 0.5 g of gel, which equals to 5 mg IBP powder, was diluted in 50 mL of PBS pH 7.4 (100 
µg/mL). Later, around 1 mL of the solution was diluted in 9 mL of PBS pH 7.4 (10 µg/mL). Following 
that, the IBP concentration was measured using an ultraviolet spectrophotometer with a wavelength of 
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223 nm. The standard IBP concentration was required to be within the range of 90%- 110% (BPOM 
RI, 2014).  
 
Particle size determination  
The particle size of gel was determined using Particle Size Analyzer (Beckman Coulter LS 13 
320) directly without dilution in comparison with pure IBP powder dispersed in aquadest 1% w/v 
(Priani et al., 2018). 
 
In-vitro diffusion study of nanogel 
The in vitro diffusion evaluation was performed to compare between IBP-BCD inclusion 
complex gel with pure IBP gel. The experiments were conducted using HT-Tuffryn membrane in 
Franz diffusion cells with a diffusional area of 3.14 cm
2
 and 0.2 μm pore size. The receiver 
compartment was filled with 15 mL of phosphate buffer solution at a pH 7.4 (37 ± 0.5°C, 600 rpm). 
The prepared gel (1 g) was applied directly into the membrane. 5.0 mL samples of the receiving 
compartment were collected at 10, 20, 30, 45, 60, 90, 120, 150, 180, 240, 300 dan 360 minutes. The 
aliquots absorption was measured using a spectrophotometer (Shimadzu UV-1800) at the maximum 
wavelength of IBP (223 nm). The receptor phase was replaced at each sampling time by 5.0 mL of 
phosphate buffer solution (Figueiredo et al., 2016; Priani et al., 2018). This experiment was done in 
triplicate replication. 
The total amount of IBP that penetrated, per diffusion area (μg/cm2), was determined using the 




Information :  
Q = total IBP that penetrated per diffusion area (μg/cm
2
) 
Cn = concentration of IBP (μg/mL) 
V = volume of the Franz diffusion cell 
 = concentration of IBP (μg/μL) in the first sample until n-1 
S = sampling volume (mL) 




RESULT AND DISCUSSION  
Preparation of IBP-BCD inclusion complex using coprecipitation method  
The IBP-BCD inclusion complex was prepared in three different molar rates (1:1, 1:2 and 2:1) 
using the coprecipitation method based on precipitation reaction. In this method, IBP and BCD would 
precipitate simultaneously into a complex form upon passing through its saturation point (Widjaja et 
al., 2014). There were several necessary processes in the coprecipitation method used to prepare the 
inclusion complex, including dilution, homogenization, and coprecipitate formation process. In the 
dilution process, the BCD was diluted in aquadest until it reached the desired molar concentration. 
Following that, the homogenization process was done to make sure that the IBP was distributed evenly 
in the solution. Thus, it could ease the binding process of IBP and formed an inclusion complex with 
BCD. Lastly, the coprecipitate formation process was completed by the absorption of ions during 
precipitation due to the mixture of IBP and BCD crystal formation with the help of NaOH (pH 12) 
solution as the catalyst (Widjaja et al., 2014).  
The formation of the inclusion complex was affected by polarity, hydrogen bond, and molecular 
affinity. The polar water molecules moved out of the inner cavity of BCD, which was nonpolar, to the 
polar outer surface area of the complex. This event led to the increase of hydrogen bond formation. 
Further, the interaction between IBP molecules and the solvent was decreased, which led to increasing 
hydrophobic interaction due to the inclusion of IBP molecules into the nonpolar inner cavity of BCD. 
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Those interactions also elevated the affinity of BCD. Hence, The formed bond between IBP and BCD 
could not be broken when it was diluted later on (Frömming and Szejtli, 1994) 
 
Determination of IBP concentration in an inclusion complex 
The determination of total IBP concentration in the IBP-BCD inclusion complex was done to 
evaluate the successful formation of the inclusion complex. The IBP concentration in the inclusion 
complex was found to be different in each formula with a different molar rate, as shown in Table 2.  
Based on the result, the IBP-BCD inclusion complex with a molar ratio of 2:1 presented the 
highest IBP concentration (97.46%). In this case, the polarity of IBP was significantly affecting the 
amount of IBP molecule that went into the inner cavity of BCD. IBP have a carboxyl functional group 
(COOH), which is polar. However, the presence of nonpolar groups such as alkyl and benzene rings 
significantly decreased the polarity of IBP. Thus, it enabled the nonpolar BCD cavity to bind with the 
nonpolar group from two IBP molecules, which formed the inclusion complex (Liu, 2008). 
 
Table 2. IBP concentration in an inclusion complex 
Sample 
IBP concentration  
(%) 
IBP-BCD (1:1) inclusion complex 86.130 ± 0.16 
IBP-BCD (1:2) inclusion complex 74.590 ± 0.09 
IBP-BCD (2:1) inclusion complex 97.460 ± 0.21 
 
Partition coefficient determination  
The partition coefficient is a concentration ratio of a compound inside of two solvents that do 
not mix with each other. The determination of partition coefficient aims to evaluate drug absorption 
ability on the human skin membrane, which consist of the lipid bilayer. The principle of determining 
the partition coefficient is the occurrence of equilibrium between the two phases, namely polar and 
nonpolar. If the partition coefficient value is more than one, it indicated that the dissolved compound is 
more prominent in the nonpolar phase. Meanwhile, if the partition coefficient value is less than one, 
then the dissolved compound is more prominent in the polar phase (Sinko, 2011). 
In this study, PBS pH 7.4 was used as a polar solvent, and chloroform was used as a nonpolar 
solvent. The rat skin was used to represent human skin, consisting of a lipid bilayer (Agustin et al., 
2007). The result of partition coefficient determination from IBP-BCD inclusion complex powder with 
the molar rate of 1:1, 1:2 and 2:1 as well as pure IBP powder was displayed in Table 3. 
 
Table 3. Partition coefficient determination 





Pure IBP 1.380 ± 0.11 0.703 ± 0.06 
IBP-BCD (1:1) inclusion complex 0.780 ± 0.03 0.24 ± 0.07 
IBP-BCD (1:2) inclusion complex 1.280 ± 0.16 0.772 ± 0.02 
IBP-BCD (2:1) inclusion complex 0.829 ± 0.06 1.021 ± 0.14 
Information : 
1) Partition coefficient in phosphate buffer solution pH 7.4 and chloroform (1:1) 
2) Partition coefficient in phosphate buffer solution pH 7.4 and skin 
 
All of the partition coefficients of IBP-BCD inclusion complex powder (molar rate 1:1, 1:2 and 
2:1) in PBS pH 7.4 and chloroform solution showed relatively lower value than the pure IBP powder. 
This result proved that the inclusion complex formation could increase the solubility of IBP. Thus, it 
was more hydrophilic compared to the pure form of IBP (Sinko, 2011). 
On the other hand, the partition coefficient value of pure IBP in PBS pH 7.4 solution and rat 
skin was relatively lower than the other IBP-BCD inclusion complex. This condition demonstrated that 
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pure IBP was more challenging to penetrate the skin membrane. Meanwhile, the partition coefficient 
value of the IBP-BCD inclusion complex in the skin solution relatively higher compared to pure IBP. 
It revealed that the inclusion complex form relatively increased IBP penetration capability through the 
membrane compared to its pure form (Saravana Kumar et al., 2013). 
The result of partition coefficient determination in both PBS and chloroform as well as PBS and 
skin solution showed that IBP-BCD inclusion complex with a molar ratio of 2:1 had the most 
favourable value.  
 
Characterization and performance evaluation of nanogel  
Organoleptic evaluation result showed that all four gel formula could be categorized as 
homogenized semisolid form with the distinctive smell of IBP. The first formula (F1) had an opaque 
colour with a relatively thinner consistency because it only contained pure IBP powder dispersed in 
the gel carrier. Meanwhile, the other three formulas contained the IBP-BCD inclusion complex (F2, 
F3, F4) and displayed transparent colour except in F3. The pH level of all four formulas was within an 
ideal range for topical gel product, around 6-8.  
A spreadability test was performed to evaluate the ability of the gel product to spread when it 
was applied to the skin. The standard of topical spreadability is within the range of 5-7 cm. F1 
possessed the highest spreadability value due to its thinner consistency compared to the other three 
formulas of inclusion complex gel (F2, F3, F4). In addition, the IBP concentration in all four formula 
reached the standard topical drug, which was within the range of 90% and 110% (BPOM RI, 2014). 
The viscosity and rheology test was done to evaluate the gel’s consistency reflecting the liquid’s 
resistance to flow. The higher the viscosity value signifies the stronger resistance or, the thicker the 
product is. All four gel formulas held different viscosity value. The viscosity values of the gel 
containing the IBP-BCD inclusion complex (F2, F3, F4) were generally higher than the gel with pure 
IBP (F1). At 50 rpm, they had a viscosity value according to the optimum viscosity of the gel system 
(2000-4000 cps) (Garg et al., 2002). The increase of viscosity was suspected to occur due to the 
presence of BCD, a cyclic oligosaccharide molecule with a high molecular weight. Based on the 
viscosity and rheology test result, it can be concluded that the gel was categorized as a non-newton 
liquid with thixotropic rheology. Thixotropic rheology is characterized by a decrease in viscosity on 
the application of force, and the value of the turning point becomes small (Figure 1). The thixotropic 
type is considered an ideal system for topical preparation due to its ease of application to the skin 
(Priani et al., 2021; Sinko, 2011). 
 The organoleptic observation and characterization of the three IBP-BCD inclusion complex 
formulas compared with pure IBP gel display favourable criteria except for the formula with the molar 
ratio of 1:2 (Table 4). 
Table 4. Characterization and performance evaluation of nanogel 







F1 Opaque, homogen  6.98 ± 0.3 7.52 ± 0.4 1832 101.76 ± 0.15 
F2 Clear, homogen 7.28 ± 0.4 7.10 ± 0.5 2659 95.88 ± 0.10 
F3 Almost clear, 
homogen 
7.33 ± 0.1 7.01 ± 0.2 3866 90.14 ± 0.09 
F4 Clear, homogen 7.40 ± 0.5  7.20 ± 0.1 2495 96.82 ± 0.11 
Information : 
F1 = Pure IBP gel 
F2 = IBP-BCD (1:1) Inclusion complex gel  
F3 = IBP-BCD (1:2) Inclusion complex gel 
F4 = IBP-BCD (2:1) Inclusion complex gel 
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Figure 1. Rheology of pure IBP gel (F1), IBP-BCD 1:1 inclusion complex gel (F2), IBP-BCD 1:2 
inclusion complex gel (F3), IBP-BCD 2:1 inclusion complex gel (F4) 
 
Particle size determination  
Particle size measurement showed that both pure IBP powder and IBP-BCD inclusion complex 
and the gel products were characterized as nanoparticle (1-1000 nm) (Table 5). The particle size of 
pure IBP powder was smaller than the IBP-BCD inclusion complex due to the combination of 
molecules that resulted in a bigger particle size. Meanwhile, the gel product of both pure IBP and 
inclusion complex encountered a decrease in particle size. This condition occurred due to dissolving 
and stirring in the gelling process. However, this condition is favourable because the smaller its 
particle size will increase diffusion and penetration ability of the topical preparation product (Patil et 
al., 2010; Sinko, 2011). 
Table 5. Particle size determination 
Sample Dmean (nm) 
Pure IBP powder 763 
Pure IBP gel 156 
IBP-BCD (2:1) inclusion complex powder 957 
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In-vitro drug release study of nanogel 
In-vitro diffusion test was done to evaluate the percutaneous cumulative release ability of IBP 
from pure IBP gel and IBP-BCD inclusion complex with the molar ratio of 1:1, 1:2 and 2:1. 






Figure 2. The cumulative release amount of IBP from pure IBP gel (F1), IBP-BCD 1:1 inclusion 
complex gel (F2), IBP-BCD 1:2 inclusion complex gel (F3), IBP-BCD 2:1 inclusion 
complex (F4) 
 
The in-vitro diffusion study showed that the gel containing the IBP-BCD inclusion complex 
could enhance the cumulative release amount of IBP compared to pure IBP gel (Figure 2). The total 
cumulative release of IBP within 6 hours in the in vitro diffusion test for pure IBP gel was 294.74 ± 
0.12 µg.cm
-2
, IBP-BCD inclusion complex (1:1) was 678.78 ± 0.19 µg.cm
-2
, IBP-BCD inclusion 
complex (1:2) was 423.23 ± 0.07 µg.cm
-2




The transdermal nanogel drug delivery system using viscolam MAC 10 as a gelling agent has 
been shown to reduce the particle size of IBP. It provides more surface area to release drugs, thereby 
increasing the rate of release of IBP. The pure IBP gel had a relatively slower IBP release rate than the 
IBP-BCD inclusion complex gel, even though its particle size was considerably smaller (156 nm). It 
confirmed that the formation of inclusion complex could increase the total cumulative release of IBO 
in the nanogel drug delivery system (Priani et al., 2021) 
The IBP-BCD inclusion complex (2:1) displayed the best in vitro diffusion profile. This formula 
was more polar compare to other formulas with different molar rate. It formed a complex from two 
IBP molecules at a time, which its nonpolar part (alkyl group and benzene ring) enter the inner cavity 
(nonpolar) of the BCD molecule. Meanwhile, the polar part (carboxyl group) was exposed outside 
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with the polar outer surface of the BCD molecule (Liu, 2008; Sugawara and Nikaido, 2014). The 
partition coefficient value of the IBP-BCD inclusion complex (2:1) was close to 1, proven that the 
affinity of nonpolar and polar phase was the same. Thus, it was easier to penetrate (Sinko, 2011) 
 
CONCLUSION  
The gel containing ibuprofen-β-cyclodextrin inclusion complex could enhance the cumulative 
release amount of ibuprofen compared to pure ibuprofen gel. The ibuprofen-β-cyclodextrin inclusion 
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